113 related articles for article (PubMed ID: 14629726)
1. Identification and characterization of a DNase hypersensitive region of the human tyrosinase gene.
Fryer JP; Oetting WS; King RA
Pigment Cell Res; 2003 Dec; 16(6):679-84. PubMed ID: 14629726
[TBL] [Abstract][Full Text] [Related]
2. Identification and functional validation of a 5' upstream regulatory sequence in the human tyrosinase gene homologous to the locus control region of the mouse tyrosinase gene.
Regales L; Giraldo P; García-Díaz A; Lavado A; Montoliu L
Pigment Cell Res; 2003 Dec; 16(6):685-92. PubMed ID: 14629727
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
Oetting WS; King RA
Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
[TBL] [Abstract][Full Text] [Related]
4. Functional dissection of the mouse tyrosinase locus control region identifies a new putative boundary activity.
Giraldo P; Martínez A; Regales L; Lavado A; García-Díaz A; Alonso A; Busturia A; Montoliu L
Nucleic Acids Res; 2003 Nov; 31(21):6290-305. PubMed ID: 14576318
[TBL] [Abstract][Full Text] [Related]
5. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.
King RA; Pietsch J; Fryer JP; Savage S; Brott MJ; Russell-Eggitt I; Summers CG; Oetting WS
Hum Genet; 2003 Nov; 113(6):502-13. PubMed ID: 13680365
[TBL] [Abstract][Full Text] [Related]
6. Analysis of tyrosinase mutations associated with tyrosinase-related oculocutaneous albinism (OCA1).
Oetting WS; King RA
Pigment Cell Res; 1994 Oct; 7(5):285-90. PubMed ID: 7886000
[TBL] [Abstract][Full Text] [Related]
7. Polymorphic sequences of the tyrosinase gene: allele analysis on 16 OCA1 patients in Japan indicate that three polymorphic sequences in the tyrosinase gene promoter could be powerful markers for indirect gene diagnosis.
Tanita M; Matsunaga J; Miyamura Y; Dakeishi M; Nakamura E; Kono M; Shimizu H; Tagami H; Tomita Y
J Hum Genet; 2002; 47(1):1-6. PubMed ID: 11829136
[TBL] [Abstract][Full Text] [Related]
8. Sequence analysis of the human tyrosinase promoter from a patient with tyrosinase-negative oculocutaneous albinism.
Matsunaga J; Dakeishi M; Miyamura Y; Tomita Y
Pigment Cell Res; 1997; 10(1-2):64-7. PubMed ID: 9170165
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCA1). Mutations in brief no. 204. Online.
Oetting WS; Fryer JP; King RA
Hum Mutat; 1998; 12(6):433-4. PubMed ID: 10671066
[TBL] [Abstract][Full Text] [Related]
10. A cell-specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number-related expression in transgenic mice.
Ganss R; Montoliu L; Monaghan AP; Schütz G
EMBO J; 1994 Jul; 13(13):3083-93. PubMed ID: 8039502
[TBL] [Abstract][Full Text] [Related]
11. Distinct distal regulatory elements control tyrosinase expression in melanocytes and the retinal pigment epithelium.
Murisier F; Guichard S; Beermann F
Dev Biol; 2007 Mar; 303(2):838-47. PubMed ID: 17196956
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism.
King RA; Oetting WS
Pigment Cell Res; 1992; Suppl 2():249-53. PubMed ID: 1409426
[TBL] [Abstract][Full Text] [Related]
13. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation.
Oetting WS
Pigment Cell Res; 2000 Oct; 13(5):320-5. PubMed ID: 11041207
[TBL] [Abstract][Full Text] [Related]
14. Tyrosinase gene analysis in Japanese patients with oculocutaneous albinism.
Goto M; Sato-Matsumura KC; Sawamura D; Yokota K; Nakamura H; Shimizu H
J Dermatol Sci; 2004 Sep; 35(3):215-20. PubMed ID: 15381243
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the tyrosinase gene in oculocutaneous albinism.
Shibahara S
Pigment Cell Res; 1992 Nov; 5(5 Pt 2):279-83. PubMed ID: 1292010
[TBL] [Abstract][Full Text] [Related]
16. A transgenic mouse model with inducible Tyrosinase gene expression using the tetracycline (Tet-on) system allows regulated rescue of abnormal chiasmatic projections found in albinism.
Giménez E; Lavado A; Giraldo P; Cozar P; Jeffery G; Montoliu L
Pigment Cell Res; 2004 Aug; 17(4):363-70. PubMed ID: 15250938
[TBL] [Abstract][Full Text] [Related]
17. Analysis of mutations in the copper B binding region associated with type I (tyrosinase-related) oculocutaneous albinism.
Oetting WS; King RA
Pigment Cell Res; 1992 Nov; 5(5 Pt 2):274-8. PubMed ID: 1292009
[TBL] [Abstract][Full Text] [Related]
18. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism.
Oetting WS; King RA
Hum Genet; 1992 Nov; 90(3):258-62. PubMed ID: 1487241
[TBL] [Abstract][Full Text] [Related]
20. Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.
Dolinska MB; Kus NJ; Farney SK; Wingfield PT; Brooks BP; Sergeev YV
Pigment Cell Melanoma Res; 2017 Jan; 30(1):41-52. PubMed ID: 27775880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
